Aprea Therapeutics Inc
Biotechnology
Healthcare
APRE
5.94 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
1.66
52 week high
4.50
high
1.66
52 week low
1.59
low
1.55
growth
-66.67 %
previous Close
1.64
P/E ratio
market cap
16.58 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-3.78 M
-9.04 %
eps
0.00 %
-10.34 %
eps surprise
13.51 %
net profit margin
-378376900.00 %
617.00 %
operating incoming
-4.10 M
-6.50 %
net change in cash
-2.44 M
33.48 %
cash on hand
26.25 M
-8.52 %
cost of revenue
0.00 %
top top